Systematic discovery of pseudomonad genetic factors involved in sensitivity to tailocins

Sean Carim1, Ashley L Azadeh2, Alexey E Kazakov3

  • 1Department of Plant and Microbial Biology, University of California, Berkeley, CA, USA.

The ISME Journal
|March 2, 2021
PubMed

Insights

Tailocins, bacterial toxins, target specific strains. Their O-antigen and lipopolysaccharide (LPS) structure are key to sensitivity, offering potential for precision antibacterial therapies and microbiome control.

Area of Science:

  • Microbiology
  • Bacteriology
  • Genomics

Background:

  • Tailocins are protein complexes from bacteria that kill related strains, influencing microbial communities.
  • Their high specificity suggests potential as precision antibacterial agents.
  • Lipopolysaccharide (LPS) is a known tailocin receptor, but sensitivity factors and resistance mechanisms are not fully understood.

Purpose of the Study:

  • To identify genetic factors influencing bacterial sensitivity to tailocins.
  • To elucidate mechanisms of tailocin resistance in producing strains.
  • To explore tailocin applications in microbiome manipulation and therapy.

Main Methods:

  • Genome-wide screens were performed in four non-model pseudomonad species to find mutants with altered tailocin sensitivity.
  • Mutant fitness was assessed in the presence of tailocins from closely related pseudomonads.
  • Findings were validated and extended to 130 sequenced pseudomonad genomes.

Main Results:

  • O-antigen composition and display were identified as critical determinants of tailocin sensitivity.
  • LPS thinning was suggested as a mechanism for increased tailocin sensitivity in resistant strains.
  • Novel insights into tailocin-bacteria interactions and sensitivity determinants were uncovered.

Conclusions:

  • Tailocin sensitivity is significantly influenced by O-antigen and LPS structure.
  • Understanding these interactions can guide the development of tailocin-based antibacterial strategies.
  • This research provides a foundation for utilizing tailocins in therapeutic and microbiome applications.